Olivier Richer

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Pierre Quartier, Florence Allantaz, Rolando Cimaz et al. · Annals of the Rheumatic Diseases · 2010 · 549 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

Mevalonate Kinase Deficiency: A Survey of 50 Patients

Brigitte Bader‐Meunier, Benoît Florkin, Jean Sibilia et al. · PEDIATRICS · 2011 · 218 citations

Medicine, Immunology, Molecular Medicine +12

Abdominal manifestations in childhood-onset systemic lupus erythematosus

Olivier Richer, Tim Ulinski, I. Lemelle et al. · Annals of the Rheumatic Diseases · 2006 · 109 citations · Full text

Medicine, Nephrology, Pediatrics +11

Safety and efficacy of anti–tumor necrosis factor α therapy in ten patients with recent‐onset refractory reactive arthritis

Alain Meyer, Emmanuel Chatelus, Daniel Wendling et al. · Arthritis & Rheumatism · 2011 · 81 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

Naïm Ouldali, Haleh Bagheri, Francesco Salvo et al. · The Lancet Regional Health - Europe · 2022 · 69 citations · Full text

Medicine, Infectious Diseases, Pediatrics +16